Active, moderate-to-severe TED research hub

Interventional, open-label, single-group, long-term follow-up trial of Lu AG22515 in patients with moderate-to-severe Thyroid Eye Disease

This study looks at an experimental medicine called Lu AG22515 for adults with moderate-to-severe Thyroid Eye Disease. Researchers want to see if the drug is safe and whether it can reduce eye bulging over 24 weeks, followed by long-term monitoring of the participants' health.